+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new class of anti-cancer drugs: HDAC-inhibitors



A new class of anti-cancer drugs: HDAC-inhibitors



I Supplementi di Tumori 1(4): S66




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079396

Download citation: RISBibTeXText

PMID: 12415827


Related references

Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. Journal of Medicinal Chemistry 61(6): 2589-2603, 2018

The forgotten class of drugs for multiple myeloma: HDAC inhibitors. Lancet. Haematology 5(12): E604-E605, 2018

An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Chemico-Biological Interactions 253: 112-124, 2016

HDAC inhibitors: A new promising drug class in anti-aging research. Mechanisms of Ageing and Development 166: 6, 2017

Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes. Biochimica et Biophysica Acta 1834(1): 317-328, 2013

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC. British Journal of Haematology 162(4): 559-562, 2013

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites. International Journal for Parasitology. Drugs and Drug Resistance 5(3): 117-126, 2015

HDAC Inhibitors as Novel Anti-Cancer Therapeutics. Recent Patents on Anti-Cancer Drug Discovery 10(2): 145-162, 2015

Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer. Medicinal Research Reviews 38(6): 2058-2109, 2018

Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat. Plos one 11(6): E0156421, 2016

Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells. European Journal of Histochemistry 48(3): 273-290, 2004

Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery. Archives of Pharmacal Research 35(2): 197-200, 2012

Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells. Biochemical and Biophysical Research Communications 445(2): 320-326, 2014

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy. Journal of Ovarian Research 5(1): 12, 2012

Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. European Journal of Medicinal Chemistry 95: 104-115, 2015